Magnetic resonance imaging ( <scp>MRI</scp> )‐guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised <scp>MRI</scp> ‐based moulds

Abstract

MRI-guided transurethral US therapy enabled safe and targeted ablations of prescribed lesions in a preclinical canine prostate model. Ablation volumes were reliably predicted by intra- and post-procedural imaging. Clinical studies are needed to confirm the feasibility, safety, oncological control, and functional outcomes of this therapy in patients in whom focal therapy is indicated.